» Articles » PMID: 18378801

Differential Block of Sensory Neuronal Voltage-gated Sodium Channels by Lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], Lidocaine, and Carbamazepine

Overview
Specialty Pharmacology
Date 2008 Apr 2
PMID 18378801
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Voltage-gated sodium channels play a critical role in excitability of nociceptors (pain-sensing neurons). Several different sodium channels are thought to be potential targets for pain therapeutics, including Na(v)1.7, which is highly expressed in nociceptors and plays crucial roles in human pain and hereditary painful neuropathies, Na(v)1.3, which is up-regulated in sensory neurons following chronic inflammation and nerve injury, and Na(v)1.8, which has been implicated in inflammatory and neuropathic pain mechanisms. We compared the effects of lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], a new pain therapeutic, with those of lidocaine and carbamazepine on recombinant Na(v)1.7 and Na(v)1.3 currents and neuronal tetrodotoxin-resistant (Na(v)1.8-type) sodium currents using whole-cell patch-clamp electrophysiology. Lacosamide is able to substantially reduce all three current types. However, in contrast to lidocaine and carbamazepine, 1 mM lacosamide did not alter steady-state fast inactivation. Inhibition by lacosamide exhibited substantially slower kinetics, consistent with the proposal that lacosamide interacts with slow-inactivated sodium channels. The estimated IC(50) values for inhibition by lacosamide of Na(v)1.7-, Na(v)1.3-, and Na(v)1.8-type channels following prolonged inactivation were 182, 415, and 16 microM, respectively. Na(v)1.7-, Na(v)1.3-, and Na(v)1.8-type channels in the resting state were 221-, 123-, and 257-fold less sensitive, respectively, to lacosamide than inactivated channels. Interestingly, the ratios of resting to inactivated IC(50)s for carbamazepine and lidocaine were much smaller (ranging from 3 to 16). This suggests that lacosamide should be more effective than carbamazepine and lidocaine at selectively blocking the electrical activity of neurons that are chronically depolarized compared with those at more normal resting potentials.

Citing Articles

Voltage-gated sodium channels in excitable cells as drug targets.

Alsaloum M, Dib-Hajj S, Page D, Ruben P, Krainer A, Waxman S Nat Rev Drug Discov. 2025; .

PMID: 39901031 DOI: 10.1038/s41573-024-01108-x.


[Additional experience with medicinal treatment of trigeminal nerve pain].

Liedtke W Schmerz. 2024; 38(5):359-361.

PMID: 39141098 DOI: 10.1007/s00482-024-00820-2.


Persistent sodium currents in neurons: potential mechanisms and pharmacological blockers.

Muller P, Draguhn A, Egorov A Pflugers Arch. 2024; 476(10):1445-1473.

PMID: 38967655 PMC: 11381486. DOI: 10.1007/s00424-024-02980-7.


Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects.

Fogel E, Easler J, Yuan Y, Yadav D, Conwell D, Vege S JMIR Res Protoc. 2024; 13:e50513.

PMID: 38451604 PMC: 10958339. DOI: 10.2196/50513.


Stem cells and pain.

da Silva M, Piva M, Martelossi-Cebinelli G, Stinglin Rosa Ribas M, Hoffmann Salles Bianchini B, Heintz O World J Stem Cells. 2024; 15(12):1035-1062.

PMID: 38179216 PMC: 10762525. DOI: 10.4252/wjsc.v15.i12.1035.